We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




AI-Powered Algorithm Automates Analysis of Coronary Stents After Implantation

By HospiMedica International staff writers
Posted on 30 Apr 2025

Every year, over three million people globally receive stents to open blocked blood vessels caused by heart disease. More...

However, monitoring the healing process after stent implantation remains a significant challenge. If the tissue growing over the stent becomes irregular—either growing too thick or forming deposits—it can lead to complications such as re-narrowing or occlusion of the blood vessel. Currently, analyzing these healing patterns in intravascular optical coherence tomography (OCT) images is time-consuming and impractical for routine clinical use. Now, a new artificial intelligence (AI)-driven algorithm automates the analysis of coronary stents post-implantation, achieving the accuracy of medical experts while dramatically reducing the time required for assessment. With robust validation in both human and animal models, this AI algorithm has the potential to standardize post-stent monitoring, thereby improving cardiovascular treatment outcomes.

DeepNeo, the AI algorithm developed by researchers from Helmholtz Munich (Oberschleißheim, Germany) in collaboration with other experts, can automatically assess stent healing in OCT images. DeepNeo differentiates between various healing patterns with accuracy comparable to clinical experts but at a fraction of the time. The AI tool also provides precise measurements, such as tissue thickness and stent coverage, offering valuable insights for patient management. To train DeepNeo, the researchers used 1,148 OCT images from 92 patient scans, which were manually annotated to classify different types of tissue growth. The algorithm was then tested on an animal model, where it accurately identified unhealthy tissue in 87% of cases, compared to detailed laboratory analysis, which is considered the gold standard. When analyzing human scans, DeepNeo also demonstrated high precision, closely aligning with expert assessments.

“With DeepNeo, we can achieve an automated, standardized, and highly accurate analysis of stent and vascular healing that was previously only possible through extensive manual effort,” said Valentin Koch, first author of the study introducing the algorithm. “DeepNeo is as good as a doctor, but much faster.”

“DeepNeo demonstrates how machine learning can support clinicians in making quicker, more informed treatment decisions. The next step is now to effectively integrate AI algorithms like DeepNeo into clinical practice,” added Dr. Carsten Marr, Director at the Institute of AI for Health at Helmholtz Munich, who envisions DeepNeo as part of an AI-powered healthcare system that could offer unprecedented certainty for clinical decision-making.

Related Links:
Helmholtz Munich


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Needle Guide Disposable Kit
Verza
New
Mattress System
Apollo Infant Dynamic
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.